Angiogenesis plays a central role in many disease processes, and it is expected that modulation of angiogenesis will provide therapeutic benefit. Our proposed study of the mechanisms of cerebral angiogenesis has potential ramifications for patients with cerebral vascular malformations, stroke, and viral infections of the brain. Little is known of how blood vessels develop in response to anglogenic stimuli in the adult brain. We will define the mechanisms of blood vessel formation in the brain and determine whether angiogenesis in the brain differs from that in other tissues. We will use a model that we have developed for cerebral inoculation of adenoviral vector encoding for vascular permeability factor/ vascular endothelial growth factor (VPF/VEGF) in athymic mice. Using techniques of detailed histology and morphometrics, in situ hybridization, cell proliferation and apoptosis studies, and 3-dimensional microscopy, we will examine the detailed mechanisms of how blood vessels develop in the brain. From these studies we will learn what vessels give rise to the new vessels, how they divide into smaller vessels, and the steps and processes involved in the maturation of these newly formed vessels. We will answer the question of whether the vessels formed in the brain by adenoVPF/VEGF differ from normal cerebral blood vessels. The blood brain barrier is unique to cerebral vasculature. Using radio-labeled and fluorescent tracers in addition to electron microscopy, we will examine the effects of VPF/VEGF on normal brain blood vessels and study the mechanistic pathways by which permeability occurs across the blood brain barrier. We will examine the integrity of the blood brain barrier in newly formed vessels throughout the stages of angiogenesis. To test the hypothesis that VPF/VEGF induced formation of cerebral vascular malformations is augmented by ischemia, we will develop a model of chronic cerebral ischemia. We will use this model to determine how mechanisms of angiogenesis are altered in the presence of ischemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08NS002236-05
Application #
6844739
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Tom P
Project Start
2001-02-06
Project End
2005-09-15
Budget Start
2005-02-01
Budget End
2005-09-15
Support Year
5
Fiscal Year
2005
Total Cost
$53,730
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Lim, Young-Min; Cho, Yong-Won; Shamim, Sadat et al. (2008) Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res 82:183-9
Theodore, William H; Epstein, Leon; Gaillard, William D et al. (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49:1828-37
Hasler, Gregor; Bonwetsch, Robert; Giovacchini, Giampiero et al. (2007) 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62:1258-64
Giovacchini, Giampiero; Toczek, Maria T; Bonwetsch, Robert et al. (2005) 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 46:1128-35
Stiver, S I; Tan, X; Brown, L F et al. (2004) VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol 63:841-55
Stiver, Shirley I (2004) Angiogenesis and its role in the behavior of astrocytic brain tumors. Front Biosci 9:3105-23